.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...
.Aelis Farma's chances of getting an easy, beneficial selection on a $100 million alternative remitt...
.ProKidney has ceased some of a pair of phase 3 trials for its cell treatment for renal disease afte...
.Vaxcyte introduced what analysts called "impressive" stage 1/2 data for its 31-valent pneumococcal ...
.Recursion has stumbled by means of an early examination of its tech-enabled approach to medicine re...
.Call it a situation of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning scie...
.Practice Precision Medicines has actually racked up yet another midphase win in epilepsy this year,...
.After getting away from a professional grip numerous years back, Dyne Rehab has actually revealed n...
.Arrowhead Pharmaceuticals has presented its own hand ahead of a potential face-off with Ionis, publ...
.Pfizer as well as Valneva may possess about two more years to stand by prior to they help make the ...